methoxyhydroxyphenylglycol has been researched along with vu0092273 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavallo, D; Gerace, E; Giovannini, MG; Henley, JM; Lana, D; Landucci, E; Pellegrini-Giampietro, DE; Ugolini, F | 1 |
1 other study(ies) available for methoxyhydroxyphenylglycol and vu0092273
| Article | Year |
|---|---|
Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors.
Topics: Allosteric Regulation; Animals; Brain Ischemia; CA1 Region, Hippocampal; Disease Models, Animal; Down-Regulation; Gliosis; In Vitro Techniques; Methoxyhydroxyphenylglycol; Neuroglia; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-akt; Rats; Receptor, Metabotropic Glutamate 5; Receptors, AMPA; Receptors, Metabotropic Glutamate | 2020 |